Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Retained Earnings (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Retained Earnings for 3 consecutive years, with -$613.0 million as the latest value for Q1 2026.

  • Quarterly Retained Earnings fell 30.93% to -$613.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$613.0 million through Jan 2026, down 30.93% year-over-year, with the annual reading at -$520.2 million for FY2025, 28.0% down from the prior year.
  • Retained Earnings for Q1 2026 was -$613.0 million at Kestra Medical Technologies, down from -$578.9 million in the prior quarter.
  • The five-year high for Retained Earnings was -$406.4 million in Q2 2024, with the low at -$613.0 million in Q1 2026.
  • Average Retained Earnings over 3 years is -$522.1 million, with a median of -$533.2 million recorded in 2025.
  • The sharpest move saw Retained Earnings decreased 28.0% in 2025, then plummeted 30.93% in 2026.
  • Over 3 years, Retained Earnings stood at -$406.4 million in 2024, then tumbled by 42.42% to -$578.9 million in 2025, then dropped by 5.9% to -$613.0 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$613.0 million, -$578.9 million, and -$546.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.